BioInfra Life Science Statistics
Total Valuation
BioInfra Life Science has a market cap or net worth of KRW 4.00 billion.
Market Cap | 4.00B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BioInfra Life Science has 14.09 million shares outstanding.
Shares Outstanding | 14.09M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 37.57% |
Owned by Institutions (%) | 2.41% |
Float | 8.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.15 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67
Current Ratio | 1.67 |
Quick Ratio | 1.66 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -3.54 |
Interest Coverage | -12.02 |
Financial Efficiency
Return on equity (ROE) is -746.61% and return on invested capital (ROIC) is -37.22%.
Return on Equity (ROE) | -746.61% |
Return on Assets (ROA) | -28.10% |
Return on Capital (ROIC) | -37.22% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.23 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.75% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -36.75% |
50-Day Moving Average | 323.06 |
200-Day Moving Average | 329.61 |
Relative Strength Index (RSI) | 45.75 |
Average Volume (20 Days) | 25,764 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioInfra Life Science had revenue of KRW 1.78 billion and -3.59 billion in losses. Loss per share was -266.28.
Revenue | 1.78B |
Gross Profit | 825.48M |
Operating Income | -3.55B |
Pretax Income | -3.59B |
Net Income | -3.59B |
EBITDA | -3.18B |
EBIT | -3.55B |
Loss Per Share | -266.28 |
Balance Sheet
The company has 7.49 billion in cash and 10.46 billion in debt, giving a net cash position of -2.97 billion or -210.80 per share.
Cash & Cash Equivalents | 7.49B |
Total Debt | 10.46B |
Net Cash | -2.97B |
Net Cash Per Share | -210.80 |
Equity (Book Value) | -1.21B |
Book Value Per Share | -102.70 |
Working Capital | 3.58B |
Cash Flow
In the last 12 months, operating cash flow was -2.87 billion and capital expenditures -81.61 million, giving a free cash flow of -2.95 billion.
Operating Cash Flow | -2.87B |
Capital Expenditures | -81.61M |
Free Cash Flow | -2.95B |
FCF Per Share | -209.72 |
Margins
Gross margin is 46.40%, with operating and profit margins of -199.78% and -202.04%.
Gross Margin | 46.40% |
Operating Margin | -199.78% |
Pretax Margin | -202.04% |
Profit Margin | -202.04% |
EBITDA Margin | -178.62% |
EBIT Margin | -199.78% |
FCF Margin | -166.11% |
Dividends & Yields
BioInfra Life Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.59% |
Shareholder Yield | 2.59% |
Earnings Yield | -93.76% |
FCF Yield | -73.84% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |